These Analysts Cut Their Forecasts On TransMedics Group Following Weak Results

TransMedics Group, Inc. (NASDAQ:TMDX) posted downbeat quarterly results on Monday.

TransMedics reported quarterly earnings of 12 cents per share which missed the analyst consensus estimate of 30 cents per share. The company reported quarterly sales of $108.76 million which missed the analyst consensus estimate of $115.00 million.

"We are proud of our performance year to date and look forward to ending 2024 on a strong note," said Waleed Hassanein, president and CEO of TransMedics. "We continued to make meaningful progress across each of our growth initiatives through the third quarter and maintain our conviction in our ...